Commentary & Deal Flow

Launched:
Long 3yr: €700m @ MS+30bp - Books >€1.9bn
6yr: €600m @ MS+50bp - Books >€1.7bn
9yr: €500m @ MS+68bp - Books >€1.4bn
12yr: €750m @ MS+83bp - Books >€1.8bn
Spread set at: Long 3yr: MS+30bp 6yr: MS+50bp 9yr: MS+68bp 12yr: MS+83bp - Combined Books above €6.8bn (pre-rec)
Guidance:
Long 3yr: MS+30/35bp - Books >€2.0bn
6yr: MS+50/55bp - Books >€2.1bn
9yr: MS+70a (+/-2) - Books >€1.6bn
12yr: MS+85a (+/-2) - Books >€2.7bn
Combined Books above €8.5bn (pre-rec)
IPTs:
Long 3yr: MS+60a
6yr: MS+80a
9yr: MS+95/100bp
12yr: MS+115a

• Issuer: AstraZeneca Finance LLC (Ticker: AZN)
• Issuer LEI: 549300C3HATU4Q460S18
• Guarantor: AstraZeneca PLC
• Guarantor LEI: PY6ZZQWO2IZFZC3IOL08
• Guarantor Ratings: A1 (positive) / A+ (stable) (Moody's / S&P)
• Expected Issue Ratings: A1 / A+ (Moody's / S&P)
• Format of the Notes: Senior, Unsecured, Reg S, Registered, NSS
• Size:
  • Long 3yr: €700m
  • 6yr: €600m
  • 9yr: €500m
  • 12yr: €750m
• Ranking: Senior Unsecured
• Settlement Date: 01-Sep-26 (T+5)
• Maturity Date:
  • Long 3yr: 01-Mar-30
  • 6yr: 01-Sep-32
  • 9yr: 01-Sep-35
  • 12yr: 01-Sep-38
• Reference Benchmark:
  • Long 3yr: DBR 0.000% due 15-Feb-30 (ISIN: DE0001102499)
  • 6yr: DBR 1.700% due 15-Aug-32 (ISIN: DE0001102606)
  • 9yr: DBR 2.600% due 15-Aug-35 (ISIN: DE000BU2Z056)
  • 12yr: DBR 1.000% due 15-May-38 (ISIN: DE0001102598)
• Coupon: Fixed, Ann, Act / Act (ICMA), Short First on the Long 3-year
• Denominations: €100k + 1k
• Business Days: London, T2
• Early Redemption: 1m Par Call (Long 3-year), 3m Par Call (6-, 9- and 12-years), MWC, Clean-up Call (75%)
• ISIN / Common Code:
  • Long 3yr: XS3484302206 / 348430220
  • 6yr: XS3484302461 / 348430246
  • 9yr: XS3484302545 / 348430254
  • 12yr: XS3484302628 / 348430262
• UOP: General Corporate Purposes
• Docs: Euro Medium Term Note Programme dated 09-Jun-26, London Stock Exchange (Main Market), English Law
• Canadian Sales: Yes, via exemption
• Target Market: MiFID II and UK MiFIR professionals/ECPs-only / No EEA PRIIPs KID or DISC disclosure document – Manufacturer target market (MiFID II product governance and UK MiFIR product governance rules) is eligible counterparties and professional clients only (all distribution channels). No EEA PRIIPs key information document (“KID”) or disclosure document required by the FCA Product Disclosure Sourcebook (“DISC”) has been prepared as the Notes are not deemed within scope / not available to retail in the EEA or the United Kingdom
• Advertisement: The Base Prospectus is available on the London Stock Exchange www.londonstockexchange.com/exchange/news/market-news/market-news-home and the Final Terms, when published, will also be available on the same website
• Active Bookrunners: Barclays, Goldman Sachs International, Morgan Stanley
• B&D: MS
• Books Subject: 12h30 UKT
• Timing: Books open, Today's business